annual total assets:
$1.50B+$12.44M(+0.83%)Summary
- As of today (July 7, 2025), RARE annual total assets is $1.50 billion, with the most recent change of +$12.44 million (+0.83%) on December 31, 2024.
- During the last 3 years, RARE annual total assets has fallen by -$18.94 million (-1.24%).
- RARE annual total assets is now -14.55% below its all-time high of $1.76 billion, reached on December 31, 2020.
Performance
RARE Total assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total assets:
$1.31B-$191.53M(-12.74%)Summary
- As of today (July 7, 2025), RARE quarterly total assets is $1.31 billion, with the most recent change of -$191.53 million (-12.74%) on March 31, 2025.
- Over the past year, RARE quarterly total assets has increased by +$4.85 million (+0.37%).
- RARE quarterly total assets is now -25.44% below its all-time high of $1.76 billion, reached on December 31, 2020.
Performance
RARE quarterly total assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total assets Formula
Total Assets = Current Assets + Non-Current Assets
RARE Total assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.8% | +0.4% |
3 y3 years | -1.2% | -5.2% |
5 y5 years | +32.4% | +6.4% |
RARE Total assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -2.7% | +0.8% | -18.9% | +6.0% |
5 y | 5-year | -14.6% | +32.4% | -25.4% | +6.0% |
alltime | all time | -14.6% | >+9999.0% | -25.4% | +2099.4% |
RARE Total assets History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $1.31B(-12.7%) |
Dec 2024 | $1.50B(+0.8%) | $1.50B(-2.3%) |
Sep 2024 | - | $1.54B(-4.9%) |
Jun 2024 | - | $1.62B(+23.8%) |
Mar 2024 | - | $1.31B(-12.3%) |
Dec 2023 | $1.49B(-3.5%) | $1.49B(+20.4%) |
Sep 2023 | - | $1.24B(-5.6%) |
Jun 2023 | - | $1.31B(-5.2%) |
Mar 2023 | - | $1.38B(-10.5%) |
Dec 2022 | $1.55B(+1.5%) | $1.55B(-4.5%) |
Sep 2022 | - | $1.62B(+22.6%) |
Jun 2022 | - | $1.32B(-4.6%) |
Mar 2022 | - | $1.38B(-9.1%) |
Dec 2021 | $1.52B(-13.5%) | $1.52B(+2.5%) |
Sep 2021 | - | $1.48B(-1.8%) |
Jun 2021 | - | $1.51B(-5.3%) |
Mar 2021 | - | $1.60B(-9.2%) |
Dec 2020 | $1.76B(+55.0%) | $1.76B(+38.7%) |
Sep 2020 | - | $1.27B(-3.5%) |
Jun 2020 | - | $1.31B(+6.6%) |
Mar 2020 | - | $1.23B(+8.6%) |
Dec 2019 | $1.14B | $1.14B(+29.0%) |
Sep 2019 | - | $879.94M(-8.2%) |
Jun 2019 | - | $958.93M(-4.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $1.01B(+40.1%) |
Dec 2018 | $719.56M(+46.6%) | $719.56M(-6.0%) |
Sep 2018 | - | $765.14M(-5.1%) |
Jun 2018 | - | $806.02M(-1.4%) |
Mar 2018 | - | $817.35M(+66.6%) |
Dec 2017 | $490.75M(-9.2%) | $490.75M(+12.8%) |
Sep 2017 | - | $435.05M(-12.6%) |
Jun 2017 | - | $497.54M(-8.8%) |
Mar 2017 | - | $545.82M(+1.0%) |
Dec 2016 | $540.63M(-3.4%) | $540.63M(+4.9%) |
Sep 2016 | - | $515.17M(+6.9%) |
Jun 2016 | - | $481.95M(-8.1%) |
Mar 2016 | - | $524.18M(-6.3%) |
Dec 2015 | $559.57M(+182.7%) | $559.57M(-7.1%) |
Sep 2015 | - | $602.13M(+75.5%) |
Jun 2015 | - | $343.00M(-3.6%) |
Mar 2015 | - | $355.84M(+79.7%) |
Dec 2014 | $197.97M(+231.9%) | $197.97M(-6.1%) |
Sep 2014 | - | $210.93M(+29.7%) |
Jun 2014 | - | $162.59M(-5.9%) |
Mar 2014 | - | $172.71M(+189.5%) |
Dec 2013 | $59.65M(-32.5%) | $59.65M(-13.0%) |
Sep 2013 | - | $68.59M(-22.3%) |
Dec 2012 | $88.32M(+628.1%) | $88.32M |
Dec 2011 | $12.13M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual total assets?
- What is the all time high annual total assets for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual total assets year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly total assets?
- What is the all time high quarterly total assets for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly total assets year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual total assets?
The current annual total assets of RARE is $1.50B
What is the all time high annual total assets for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual total assets is $1.76B
What is Ultragenyx Pharmaceutical Inc. annual total assets year-on-year change?
Over the past year, RARE annual total assets has changed by +$12.44M (+0.83%)
What is Ultragenyx Pharmaceutical Inc. quarterly total assets?
The current quarterly total assets of RARE is $1.31B
What is the all time high quarterly total assets for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly total assets is $1.76B
What is Ultragenyx Pharmaceutical Inc. quarterly total assets year-on-year change?
Over the past year, RARE quarterly total assets has changed by +$4.85M (+0.37%)